Speakers

Mitra Tavakkoli, MD, PharmD

VP of clinical development and Head of Drug Safety
Sangamo Therapeutics
USA

Arun Srivastava

Professor
University of Florida College of Medicine
USA

Jeff Chaffin

Market Access Strategy and Contracting Consultant
Miles Payer Strategy
USA

Hildegund Ertl

Professor
The Wistar Institute
USA

Rachel Legmann

Senior Director of Technology, GCT & & Thought Leader
Repligen Corporation
USA

Sophie Blondel

Founder and CEO
Fox-Bio
France

Deyaa Shaheen

Founder
XFDA PHARMA ADVISORS CONSULTANTING SERVICES
USA

Curtis Kugel

Manager, ZS
USA

Rajiv Gangurde

Director
Vice President, Technical Operations, Cell & Gene Therapy
Parexel
USA

Anis Khimani, Ph.D.,

Senior Manager
Global Product Management,
Antylia Scientific
USA

Andrew Steinsapir

Director, Gene Therapy Program Lead
Deerfield Discovery and Development
USA

Mehmet Karaca
(Poster Presentation)

Director
Molecular Biology-Sequencing
Sarepta Therapeutics
USA

Chris A. Learn

Senior Vice President
Cell and Gene Therapy Center of Excellence
Parexel International
USA

Daya Verma

(Panel Discussion)

Director
TRD Project & PORTFOLIO MANAGEMENT / TECHNICAL R&D GDD
Novartis Pharmaceuticals Corporation
USA

Amanda Moore

CEO
Angelman Syndrome Foundation
USA

Kok-Seong Lim

Independent Consultant
USA

Volney L. Sheen, MD, PhD

Associate Professor of Neurology,
Harvard Medical School
USA

Melissa Penn
(Panel Discussion)

Bayer Pharmaceuticals,
USA

​Daniel C. Chung

Chief Medical Officer
Beacon Therapeutics
USA

Molly S. McGlaughlin

Chief Executive Officer
Revolution Biomanufacturing Inc
USA

Devyn Smith

Chief Executive Officer
Arbor Biotechnologies
USA

Alonza Cruse

Ex-FDA
Director, Office of Pharmaceutical Quality Operations
USA

Nermin Ibreljic

 Principal Engineer, Gene Therapy
Sarepta Therapeutics
USA

Rachel Smith

 Parexel, Vice President
Rare and Genetic Disease
USA

Patrick Starremans
(Panel Discussion)

Head of Analytical Sciences
Solid Biosciences Inc.
USA

Emily Moran

Founder
Vector Biolabs
USA

José Vázquez
(Poster Presentation)

Key Account Manager
c-LEcta GmbH
Germany

Mihir N. Shukla

𝗙𝗼𝘂𝗻𝗱𝗲𝗿 & 𝗖𝗘𝗢
Biopharma Consulting Solutions, LLC
USA

Daozhan Yu

President and CEO
AAVnerGene Inc.
USA

Celia Goeldner
(Delegate)

Clinical Expert Team Leader
Roche.
USA

Wai Lydia Tai, PhD

Schepens Eye Research Institute of Massachusetts Eye and Ear ,Department of Ophthalmology
Harvard Medical School.
USA

Larry Forman

Founder and CEO
CHO Plus, Inc
USA

Jeremy Shelley

Director of Business Development
Form Bio
USA

Brian Tomkowicz, PhD

Vice-President, Head of R&D & Virology Fellow
SK pharmteco
USA

Greg Hermetet
(Delegate)

Executive Director,
SK pharmteco
USA

Z. GAO

COO, CoFounder,
Uni-Pioneers Bio-Med, Inc

Michael DiBiasio-White
(Panel discussion)

Founder-Principal Consultant,
ViroSpark BioConsulting
USA

Bhushan Surve
(Delegate )

Sr. Global Director Business Development & Head of Marketing,
CoJourney
USA

David Greenwald
(Panel disussion )

Deerfield Management,
Managing Director
USA

Hongwei Zhang
(Panel disussion )

Principal Consultant and Founder,
HZ Independent BioConsulting
USA